These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8986323)

  • 21. Glucose, insulin, and open field responses to immobilization in nonobese diabetic (NOD) mice.
    Amrani A; Chaouloff F; Mormede P; Dardenne M; Homo-Delarche F
    Physiol Behav; 1994 Aug; 56(2):241-6. PubMed ID: 7938233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
    Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
    J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure to DDT metabolite p,p'-DDE increases autoimmune type 1 diabetes incidence in NOD mouse model.
    Cetkovic-Cvrlje M; Olson M; Schindler B; Gong HK
    J Immunotoxicol; 2016; 13(1):108-18. PubMed ID: 25721050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
    Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A
    J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65).
    Pleau JM; Fernandez-Saravia F; Esling A; Homo-Delarche F; Dardenne M
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):90-5. PubMed ID: 7606872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H; Formby B
    Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.
    Saï P; Senecat O; Martignat L; Gouin E
    Clin Exp Immunol; 1994 Jul; 97(1):138-45. PubMed ID: 8033411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice.
    Saravia FE; Revsin Y; Gonzalez Deniselle MC; Gonzalez SL; Roig P; Lima A; Homo-Delarche F; De Nicola AF
    Brain Res; 2002 Dec; 957(2):345-53. PubMed ID: 12445977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.
    Wong FS; Visintin I; Wen L; Granata J; Flavell R; Janeway CA
    J Exp Med; 1998 Jun; 187(12):1985-93. PubMed ID: 9625758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent sensitivity to streptozotocin of pancreatic islets isolated from female NOD mice.
    Reddy S; Sandler S
    Autoimmunity; 1995; 22(2):121-6. PubMed ID: 8722582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic nutritional modification of the incidence of diabetes in autoimmune non-obese diabetic (NOD) mice.
    Hoorfar J; Buschard K; Dagnaes-Hansen F
    Br J Nutr; 1993 Mar; 69(2):597-607. PubMed ID: 8490012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A; Suarez WL; Power RF
    J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.
    Yang XD; Tisch R; Singer SM; Cao ZA; Liblau RS; Schreiber RD; McDevitt HO
    J Exp Med; 1994 Sep; 180(3):995-1004. PubMed ID: 8064245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse.
    Moriyama H; Abiru N; Paronen J; Sikora K; Liu E; Miao D; Devendra D; Beilke J; Gianani R; Gill RG; Eisenbarth GS
    Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10376-81. PubMed ID: 12925730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2f1 mutation induces early onset of diabetes and Sjögren's syndrome in nonobese diabetic mice.
    Salam MA; Matin K; Matsumoto N; Tsuha Y; Hanada N; Senpuku H
    J Immunol; 2004 Oct; 173(8):4908-18. PubMed ID: 15470032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
    Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
    J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral use of interferon-alpha delays the onset of insulin-dependent diabetes mellitus in nonobese diabetes mice.
    Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Fujii M; Ohashi K; Ikeda M; Kurimoto M
    J Interferon Cytokine Res; 1999 Aug; 19(8):877-9. PubMed ID: 10476932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine immuno-ontogeny of the pathogenesis of autoimmune disease in the nonobese diabetic (NOD) mouse.
    Homo-Delarche F
    ILAR J; 2004; 45(3):237-58. PubMed ID: 15229372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.